<DOC>
	<DOCNO>NCT00768209</DOCNO>
	<brief_summary>This study design determine effect single dose study medication subject without hepatic impairment . 18 24 subject participate multiple blood draw take measure level study medication blood time .</brief_summary>
	<brief_title>A Study Evaluate Pharmacokinetics VI-0521 Subjects With Hepatic Impairment</brief_title>
	<detailed_description>This study look effect single study medication three group . Each group 6 - 8 subject similar level hepatic impairment . Group 1 normal hepatic function . Groups 2 3 make subject mild moderate hepatic impairment . Subjects blood take specific interval measure study medication level . Subject participation last approximately 7 9 day .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Phentermine</mesh_term>
	<criteria>A total 18 24 subject study 3 group 68 subject per group . Group 1 consist 68 male female normal hepatic function , 18 65 year age inclusive . Groups 23 consist 68 male female per group vary degree stable hepatic impairment . Any Subject meeting follow criterion must exclude trial : 1 . Known history clinically significant arrhythmia . 2 . Acute illness , especially infection , within 2 week dose . 3 . History presence : Alcoholism drug abuse within past 2 year . Hypersensitivity idiosyncratic reaction compound related study drug relate compound . 4 . Any History Bipolar disorder psychosis , history psychiatric hospitalization , great one lifetime episode major depression . 5 . Blood donation significant blood loss within 56 day prior Day 1 . 6 . Plasma donation within 7 day prior Day 1 . 7 . Any subject participate previous clinical trial VI0521 . 8 . Any subject receive investigational drug within 30 day prior dose study . 9 . Any history glaucoma , increase intraocular pressure , medication treat increase intraocular pressure . 10 . Serum creatinine &gt; 1.5 male subject , &gt; 1.4 female subject . 11 . History kidney stone last 6 month 12 . Female subject , may pregnant , lactate . 13 . Use drug know clinical significance inhibit induce liver enzyme involve drug metabolism . 14 . Use tobacco nicotine product within last 6 month unless subject hepaticallyimpaired .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>